{"id":1172,"date":"2016-10-03T11:52:19","date_gmt":"2016-10-03T09:52:19","guid":{"rendered":"https:\/\/aliber.org\/web\/2016\/10\/03\/feder-participa-en-el-iii-foro-innovaer\/"},"modified":"2016-10-03T11:52:19","modified_gmt":"2016-10-03T09:52:19","slug":"feder-participa-en-el-iii-foro-innovaer","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2016\/10\/03\/feder-participa-en-el-iii-foro-innovaer\/","title":{"rendered":"FEDER participa en el III Foro InnovaER"},"content":{"rendered":"<p>\u00a0<\/p>\n<p>&#013;<\/p>\n<p>La Fundaci\u00f3n Medicamentos Hu\u00e9rfanos y Enfermedades Raras (MEHUER) celebra el 6 de octubre su III Foro InnovaER con el patrocinio de Janssen. La cita se desarrollar\u00e1 en el Aula Magna de la Facultad de Farmacia (Universidad de Granada).<\/p>\n<p>&#013;<\/p>\n<p>La Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras (FEDER) tomar\u00e1 parte en este primer encuentro de la mano de su Presidente, Juan Carri\u00f3n. A trav\u00e9s de ellos, Fundaci\u00f3n Mehuer busca, mediante diferentes sesiones, abordar de forma integral la realidad de las ER; en concreto, esta primera sesi\u00f3n se centrar\u00e1 en la situaci\u00f3n a nivel nacional.<\/p>\n<p>&#013;<\/p>\n<p>Para ello, se nutre de las intervenciones de Manuel P\u00e9rez Fern\u00e1ndez, Presidente de la Fundaci\u00f3n Mehuer y del Real e Ilustre Colegio Oficial de Farmac\u00e9uticos de Sevilla, Cristina Cecilia San Vicente, Medic Scientific Liaison (MSL) en Andaluc\u00eda (Janssen), Rafael R\u00edos Tamayo, Coordinador de la Unidad de Gammapat\u00edas Monoclonales del Complejo Hospitalario Universitario de Granada, Lourdes L\u00f3pez Onieva, Investigadora Postdoctoral Senior del Center for Genomic and Oncological Research (GENyO) de Granada y Premio Ayuda Investigaci\u00f3n Fundaci\u00f3n Mehuer 2016.<\/p>\n<p>&#013;<\/p>\n<p style=\"text-align: right\">03\/10\/2016.<\/p>\n<p>&#013;<\/p>\n<p>\u00a0<\/p>\n<p>&#013;<br \/>\nSource: FEDER<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 &#013; La Fundaci\u00f3n Medicamentos Hu\u00e9rfanos y Enfermedades Raras (MEHUER) celebra el 6 de octubre su III Foro InnovaER con el patrocinio de Janssen. La cita se desarrollar\u00e1 en el<a href=\"https:\/\/aliber.org\/web\/2016\/10\/03\/feder-participa-en-el-iii-foro-innovaer\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"false","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[7],"tags":[17],"class_list":["post-1172","post","type-post","status-publish","format-standard","hentry","category-socios","tag-dia-internacional"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/1172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=1172"}],"version-history":[{"count":0,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/1172\/revisions"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=1172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=1172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=1172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}